Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Calcium Channel
    (3)
  • LPL Receptor
    (2)
  • AMPK
    (1)
  • CDK
    (1)
  • DNA
    (1)
  • FLT
    (1)
  • MELK
    (1)
  • Potassium Channel
    (1)
  • S1P Receptor
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

k 201

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
JTV-519
K-201, K 201, JTV-519, JTV 519
T242391038410-88-6In house
JTV-519 is a Ca2+-dependent blocker and prevents abnormal Ca(2+) leak from the sarcoplasmic reticulum in the ischemic heart and skeletal muscle (SkM) by stabilizing the ryanodine receptors.
  • $55
In Stock
Size
QTY
JTV-519 free base
K201 free base
T11731145903-06-6
JTV-519 free base (K201 free base), known for its antiarrhythmic and cardioprotective properties, acts as a Ca2+-dependent blocker of sarcoplasmic reticulum Ca2+-stimulated ATPase (SERCA) and as a partial agonist of ryanodine receptors in striated muscle.
  • $1,520
1-2 weeks
Size
QTY
JTV-519 hemifumarate
K201 hemifumarate
T117321435938-25-2
JTV-519 hemifumarate,Antiarrhythmic and cardioprotective properties. is a Ca2+-dependent blocker of sarcoplasmic reticulum Ca2+-stimulated ATPase (SERCA) and a partial agonist of ryanodine receptors in striated muscle.
  • Inquiry Price
6-8 weeks
Size
QTY
ARUK2010489
ARUK-2010489, ARUK2010489, ARUK 2010489
T212596
ARUK2010489 (Compound 23) is a potent, selective, and brain-penetrant NUAK1 inhibitor with a pIC50 of 8.7, also exhibiting partial inhibitory activity against CDK2, CDK4, and CDK6 at micromolar concentrations, and it is applied in neurological disease research, including mechanistic studies related to Alzheimer’s disease.
  • $290
In Stock
Size
QTY
Tirasemtiv
CK-2017357
T39661005491-05-3
Tirasemtiv (CK-2017357)(CK 2017357) is a small-molecule fast-skeletal-troponin activator, with a potential treatment for muscle weakness and neuromuscular dysfunction.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
GSK2018682 HCl
T715641034687-52-9
GSK2018682 is a novel sphingosine-1-phosphate receptor 1 (s1p1) and 5 (s1p5) agonist.
  • $1,520
1-2 weeks
Size
QTY
Dibenzosuberenol
T7201010354-00-4
Dibenzosuberenol is a reactant involved in oxidation with tert-butylhydroperoxide in water for synthesis of carboxylic acids and ketones; Synthesis of tachykinin neurokinin-1 receptor antagonists; Pauson-Khand reaction mechanism studies; Mapping the active site of aziridination catalysts.
  • $1,520
6-8 weeks
Size
QTY
GSK2018682
T73601034688-30-6
GSK2018682 is an agonist of sphingosine-1-phosphate receptor (s1p1) and (s1p5) agonist(pEC50s of 7.7 and 7.2,respectively).
  • $30
In Stock
Size
QTY
VK-2019
VK2019, VK 2019
T889232044520-06-9
VK-2019 is a selective inhibitor of Epstein–Barr virus nuclear antigen 1 (EBNA1) that was developed to specifically block EBNA1 DNA-binding activity, and is currently in phase 1 development for the treatment of EBV-associated carcinomas, supporting research into viral episome maintenance, oncogenic persistence, and targeted antiviral cancer therapies.
  • $1,520
8-10 weeks
Size
QTY
Agitoxin-2 TFA
T75883
Agitoxin-2 TFA, a potent inhibitor of K+ channels, exhibits IC50 values of 201 pM and 144 pM for mK V 1.3 and mK V 1.1, respectively [1] [2].
  • Inquiry Price
Inquiry
Size
QTY